Fulgent Genetics, Inc.

NASDAQ:FLGT

Medical - Diagnostics & Research

Healthcare
$25.13 +1.89%

+$0.33 today

Market cap
$702.11M
Beta
0.92
P/E (TTM)
-7.5
EPS (TTM)
-$2.39
52W Low $13.46High $31.04

Volume 0.39M

Average 0.55M

FLGT Weighted Avg Shares

Average number of basic shares outstanding during the period, used to calculate basic EPS.

Fulgent Genetics, Inc.NASDAQ: FLGT

Weighted Avg Shares · Q1 FY2026 · quarter ended Mar 2026

Weighted avg shares grows in line with its trailing trend

Q1 FY2026 weighted avg shares of 30.88M shares rose 0.2% year over year, behind the +1.0% change in trailing-twelve-month weighted avg shares. Sequentially, it rose 0.3% from the prior quarter. Over 3 fiscal years it compounded at +0.7% a year.

Context

  • Weighted avg shares increased in 2 of the last 3 fiscal years.
  • FY2025 was the highest annual figure in the 4 fiscal years shown.

What to watch

Whether quarterly growth recovers from +0.2% toward the trailing-twelve-month pace of +1.0%.

Sources:Income StatementText generated from reported figures; not investment advice.

Latest quarterMar 2026
30.88M+0.3% QoQ
Last fiscal yearDec 2025
30.78M+1.8% YoY
LTMMar 2026
30.81M+1.0% YoY
Weighted Avg Shares past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter+0.2%——
1 year+1.8%——
3-year CAGR+0.7%——
5-year CAGR——
10-year CAGR——

Weighted Avg Shares history

Shares · from the income statement

Latest · FY2025
30.78M USD
Year-over-year change
+1.8%
4-year CAGR
+1.1%

Weighted Avg Shares vs competitors

How FLGT compares with its peers on the latest reported figures

  • FLGT's LTM Mar 2026 weighted avg shares of 30.81M shares is the 7th highest of the 8 companies compared; the peer median is 93.42M shares.
  • Its year-over-year change of +1.0% is the lowest of 8, against a peer median of +3.5%.
  • Over three fiscal years its annual growth of +0.7% compares with a peer median of +9.3%.
FLGT Competitors Peer median
Weighted Avg Shares for FLGT and competitors
Company Period LTM YoY 3-year CAGR
NTRANatera, Inc.LTM Jun 2026139.67M +7.5%+11.6%
GHGuardant Health, Inc.LTM Sep 2026131.61M +6.0%+7.1%
NEONeoGenomics, Inc.LTM Jun 2026128.84M +1.3%+1.0%
PSNLPersonalis, Inc.LTM Mar 202693.42M +36.5%+25.0%
MYGNMyriad Genetics, Inc.LTM Mar 202693.15M +2.4%+5.0%
BLLNBillionToOne, Inc.LTM Jun 202645.72M +2.2%—
FLGTFulgent Genetics, Inc.LTM Mar 202630.81M +1.0%+0.7%
WGSGeneDx Holdings Corp.LTM Jun 202628.68M +3.5%+38.0%
FRNMFreenome, Inc. Common stock—— ——
Peer median (excluding FLGT) 93.42M+3.5%+9.3%

Competitors are the stored peer set for FLGT. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue992.58M618.97M289.21M283.47M322.67M
Cost of Revenue215.53M252.07M184.76M176.26M191.8M
Gross Profit777.05M366.9M104.46M107.22M130.88M
Gross Margin78.3%59.3%36.1%37.8%40.6%
Research & Development24.22M28.91M41.44M48.82M53.91M
Selling, General & Admin75.17M149.99M130.47M124.35M160.04M
Operating Expenses101.1M188.37M299.99M181.13M221.97M
Depreciation & Amortization11M32.66M26.14M24.93M24.12M
EBITDA692.04M217.7M(147.45M)(26.86M)(45.83M)
EBITDA Margin69.7%35.2%-51.0%-9.5%-14.2%
Operating Income675.95M178.53M(195.53M)(73.92M)(91.1M)
Operating Margin68.1%28.8%-67.6%-26.1%-28.2%
Interest Income1.35M5.62M21.61M31.3M30.92M
Interest Expense01.01M488K170K75K
Other Income / Expenses5.08M5.5M21.44M21.96M21.07M
Income Before Tax681.03M184.03M(174.09M)(51.96M)(70.03M)
Pre-Tax Margin68.6%29.7%-60.2%-18.3%-21.7%
Income Tax Expense174.8M42.1M1.15M(8.14M)(8.39M)
Net Income507.36M143.4M(167.83M)(42.71M)(60.51M)
Net Margin51.1%23.2%-58.0%-15.1%-18.8%
EPS (Basic)17.134.76(5.63)(1.41)(1.97)
EPS (Diluted)16.264.63(5.63)(1.41)(1.97)
Weighted Avg Shares29.41M30.1M29.78M30.24M30.78M
Weighted Avg Shares (Diluted)30.98M30.96M29.78M30.24M30.78M

Fulgent Genetics, Inc.

NASDAQ:FLGT

Intrinsic Alpha fair value

Locked

Current Price

$25.13

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.